.
New from McKinsey & Company | COVID-19 disruptions have led many pharmas to reassess their manufacturing networks and strategies. We share four ways that pharma companies can optimize manufacturing and avoid common pitfalls. | | | | | McKinsey Insights - Get our latest thinking on your iPhone, iPad, or Android | | | | | This email contains information about McKinsey’s research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy. | You received this email because you subscribed to our Pharmaceuticals & Medical Products alert list. | | Copyright © 2022 | McKinsey & Company, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007 | | | |
No comments:
Post a Comment